Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: Effects on differentiation potential and function

Diabetologia

Volumn 57, Issue 1, 2014, Pages 246-256

  Ferrer Lorente, Raquel ^a,b   Bejar, Maria Teresa ^a   Tous, Monica ^a   Vilahur, Gemma ^a,b   Badimon, Lina ^a,b  

^a CSIC   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Adipose derived stem cells; Cell therapy; Differentiation potential; Gene expression and in silico analysis; Pluripotency; Stemness; Subcutaneous adipose tissue; Type 2 diabetes

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALANINE AMINOTRANSFERASE; BETA1 INTEGRIN; CD36 ANTIGEN; CHOLESTEROL; COLLAGEN TYPE 1; DNA METHYLTRANSFERASE 3B; ENDOGLIN; ENDOSTATIN; FATTY ACID BINDING PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; HERMES ANTIGEN; LEPTIN RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; PODXL PROTEIN; PROTEIN; SERINE PROTEINASE INHIBITOR; SERPIN PEPTIDASE INHIBITOR CLADE E; STROMAL CELL DERIVED FACTOR 1; TELOMERASE REVERSE TRANSCRIPTASE; THROMBOSPONDIN 1; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; VON WILLEBRAND FACTOR;

ADIPOSE DERIVED STEM CELL; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL RENEWAL; CELL VIABILITY; CHOLESTEROL BLOOD LEVEL; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC MODEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RAT; SUBCUTANEOUS FAT; SYSTEMS BIOLOGY; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; RATS; STEM CELLS; SUBCUTANEOUS FAT; SYSTEMS BIOLOGY;

EID: 84890903465     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3081-z     Document Type: Article

References (50)

1. Pittenger MF, Martin BJ (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9-20
2. Van der Bogt KEA, Sheikh AY, Schrepfer S et al (2008) Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 118:S121-S129
3. Kamihata H, Matsubara H, Nishiue T et al (2001) Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104:1046-1052
4. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705
5. Cleland JGF, Fremantle N, Coletta AP, Clark AL (2006) Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail 8:105-110
6. Gimble JM, Guilak F, Bunnell BA (2010) Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 1:19
7. Tepper OM, Galiano RD, Capla JM et al (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786
8. Li TS, Furutani A, Takahashi M et al (2006) Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats. Am J Physiol Heart Circ Physiol 290:H1362-H1369
9. Fadini GP, Sartore S, Schiavon M et al (2006) Diabetes impairs progenitor cell mobilization after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 49:3075-3084
10. Sharpless NE, DePinho RA (2007) How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8:703-713
11. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morpholog 16:381-390
12. Dominici M, Le Blanc K, Mueller E et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317
13. Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749
14. Da Silva ML, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213
15. Zuk PA, Zhu M, Ashjian P et al (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295
16. Gimble JM, Katz AJ, Bunnell BA (2007) Adipose-derived stem cells for regenerative medicine. Circ Res 100:1249-1260
17. Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z (2008) Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 26:664-675
18. Schäffler A, Büchler C (2007) Concise review: adipose tissue-derived stromal cells - basic and clinical implications for novel cell-based therapies. Stem Cells 25:818-827
19. Madonna R, Geng YJ, de Caterina R (2009) Adipose tissue derived stem cells: characterization and potential for cardiovascular repair. Arterioscler Thromb Vasc Biol 29:1723-1729
20. Mizuno H, Tobita M, Uysal AC (2012) Adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 30:804-810
21. Clark JB, Palmer CJ, Shaw WN (1983) The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173:68-75
22. Masiello P, Broca C, Gross R et al (1998) Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47:224-229
23. Golzelniak K, Janke J, Engeli S, Sharma AM (2001) Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. Horm Metab Res 33:625-627
24. Li YM, Schilling T, Benisch P et al (2007) Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun 363:209-215
25. Nichols J, Zevnik B, Anastassiadis K et al (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391
26. Boiani M, Schöler HR (2005) Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6:872-884
27. Riekstina U, Cakstina I, Parfejevs V et al (2009) Embryonic stem cell markers expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev Rep 5:378-386
28. Park IH, Zhao R, West JA et al (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146
29. Radtke F, Raj K (2003) The role of Notch in tumorigenesis: oncogene or tumor suppressor? Nat Rev Cancer 3:765-767
30. Nichols AM, Pan Y, Herreman A et al (2004) Notch pathway is dispensable for adypocite specification. Genesis 40:40-44
31. Garcés C, Ruiz-Hidalgo MJ, Font de Mora J et al (1997) Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem 272:29729-29734
32. Ugarte F, Ryser M, Thieme S et al (2009) Notch signalling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells. Exp Hematol 37:867-875
33. Huang Y, Yang X, Wu Y et al (2010) γ-Secretase inhibitor induces adipogenesis of adipose-derived stem cells by notch regulation of Notch and PPARγ. Cell Prolif 43:147-156
34. Laudes M (2011) Role of Wnt signalling in the determination of human mesenchymal stem cells into preadipocytes. J Mol Endocrinol 46:65-72
35. Lanner F, Rossant J (2010) The role of FGF/Erk signalling in pluripotent cells. Development 137:3351-3360
36. Zaragosi LE, Ailhaud G, Dani C (2006) Autocrine fibroblast growth factor 2 signalling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 24:2412-2419
37. Xiao L, Sobue T, Esliger A et al (2010) Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells. Bone 47:360-370
38. Kume S, Kato S, Yamagishi S et al (2005) Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res 20:1647-1658
39. Van Tienen FHJ, van der Kallen CJH, Lindsey PJ, Wanders RJ, van Grevenbroek MM, Smeets HJM (2011) Preadypocytes of type 2 diabetes subjects display an intrinsic gene expression profile of decreased differentiation capacity. Int J Obes 35:1154-1164
40. Gopalakrishnan V, Vignesh RC, Arunakaran J, Aruldhas MM, Srinivasan N (2006) Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol 84:93-101
41. Aguiari P, Leo S, Zavan B et al (2008) High glucose induces adipogenic differentiation of muscle-derived stem cells. PNAS 105:1226-1231
42. Bicknell R, Harris AL (2004) Novel angiogenic signalling pathways and vascular targets. Annu Rev Pharmacol Toxicol 44:219-238
43. Zerlin M, Julius MA, Kitajewski J (2008) Wnt/Frizzled signalling in angiogenesis. Angiogenesis 1:63-69
44. Phng LK, Gerhardt H (2009) Angiogenesis: a team effort coordinated by Notch. Dev Cell 16:196-208
45. Limbourg A, Ploom M, Elligsen D et al (2007) Notch ligand delta-like 1 is essential for postnatal arteriogenesis. Circ Res 100:363-371
46. Benedito R, Roca C, Sörensen I et al (2009) The Notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137:1124-1135
47. Dejana E (2010) The role of Wnt signalling in physiological and pathological angiogenesis. Circ Res 107:943-952
48. Zhang B, Ma J (2010) Wnt pathway antagonists and angiogenesis. Protein Cell 1:898-906
49. Chang YJ, Shih DT, Tseng CP, Hsieh TB, Lee DC, Hwang SM (2006) Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 24:679-685
50. Scheller EL, Song J, Dishowitz MI, Soki FN, Hankenson KD, Krebsbach PH (2010) Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells 28:1071-1080